Recent Updates
Recently added Catalysts
HROW Negative Sentiment Score: 25/100

Harrow Health, Inc.: Company Investigated by the Portnoy Law Firm

Key Takeaway: The Portnoy Law Firm has initiated an investigation into Harrow Health, Inc. regarding potential securities fraud. The firm's inquiry comes after allegations of undisclosed investigations by the U.S. Department of Justice and a warning letter from the FDA about misleading marketing claims. Following these revelations, Harrow's stock experienced a drop of 3.2%, significantly impacting investors. The law firm encourages affected investors to consider pursuing claims to recover their losses.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investigation into possible securities fraud affecting investor trust.
  • Stock price dropped by 3.2% due to recent negative reports.
  • Allegations of misleading marketing claims and past regulatory issues.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Harrow Health, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Harrow investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
Bonitas Research released a report on February 22, 2023, which claimed that Harrow had kept quiet about a U.S. Department of Justice investigation into its sales practices and had engaged in questionable transactions with former subsidiaries. Additionally, Harrow had not revealed that it received a warning letter from the U.S. Food and Drug Administration for misleading marketing claims. However, months later, the company issued a recall across the country. As a result of this news, Harrow's stock price dropped by 3.2%, or $0.54, to close at $16.42 on February 22, 2023, causing harm to investors.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising

Tags

Frequently Asked Questions

How can investors contact the Portnoy Law Firm?

Investors can reach out to the Portnoy Law Firm at 844-767-8529 or lesley@portnoylaw.com.

What is the investigation about Harrow Health, Inc.?

The Portnoy Law Firm is investigating possible securities fraud related to Harrow.

What issues did Bonitas Research report about Harrow?

Bonitas Research claimed Harrow concealed a DOJ investigation and received an FDA warning.

How much did Harrow's stock drop after the news?

Harrow's stock fell by 3.2% or $0.54, closing at $16.42 on February 22, 2023.

What services does the Portnoy Law Firm offer to investors?

The firm offers complimentary case evaluations and options for recovering losses.

Last updated: Feb 28, 2023